Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annual Meeting Data will be featured in an encore presentation at the...
United States Randall Kaye Encephalopathies Dees Longboard Pharmaceuticals Inc Exchange Commission Longboard Pharmaceuticals
Source: marketscreener.com